ARMO
ARMO BioSciences, Inc. Common Stock
ARMO
ARMO
Delisted
ARMO was delisted on the 21st of June, 2018.
65 hedge funds and large institutions have $509M invested in ARMO BioSciences, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 65 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
+65
Holders Change %
–
% of All Funds
1.49%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
%
% of All Funds
0.07%
New
65
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$154M |
| 2 |
AI
Alphabet Inc
Mountain View,
California
|
+$45.4M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
+$45.2M |
| 4 |
BlackRock
New York
|
+$30.8M |
| 5 |
HH
HSG Holding
Na,
Hong Kong
|
+$30.3M |
Top Sellers
No sellers this quarter
